On April 15, 2022 board of directors of Ra Medical Systems, Inc. reallocated a Class II director (with a term expiring at the 2023 annual meeting of stockholders) to Class III (with a term expiring at the 2024 annual meeting of stockholders). Accordingly, on April 20, 2022, Susanne Meline stepped down as a Class II director and was immediately reappointed to the Board as a Class III director. Concurrently, the number of Class III seats was increased by one to two seats and the number of Class II seats was reduced by one to two seats.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5256 USD | 0.00% | -8.67% | +30.00% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.00% | 3.98M | |
+7.87% | 219B | |
+11.83% | 192B | |
+18.87% | 142B | |
+30.03% | 111B | |
+2.17% | 65.32B | |
+14.15% | 52.45B | |
+2.68% | 49.8B | |
+6.60% | 43.43B | |
+1.85% | 35.95B |
- Stock Market
- Equities
- VTAK Stock
- News Catheter Precision, Inc.
- Ra Medical Systems, Inc. Reallocates Susanne Meline from Class II Director to Class III Director